首页> Expert review of precision medicine and drug development> TRAIL pathway targeting therapeutics.

TRAIL pathway targeting therapeutics.

导出 LinkOut

翻译打印收藏纠错

第一作者： Marie D,Ralff

第一单位： MD/PhD Program, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.;Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Hematology/Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA.

作者： Marie D,Ralff ^[1] ; Wafik S,El-Deiry ^[2]

作者单位： MD/PhD Program, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.;Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Hematology/Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA. ^[1] Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Hematology/Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA. ^[2]

关键词 Apoptosis DISC Imipridone TRAIL TRAIL-R agonist apoptosome atrimer cancer

DOI 10.1080/23808993.2018.1476062

PMID 30740527

发布时间 2022-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览5

Expert review of precision medicine and drug development

2018年3卷3期

197-204页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览5

点击下载本期目录封面

Expert review of precision medicine and drug development

2018年3卷3期

197-204页

检索历史清除

TRAIL pathway targeting therapeutics.

Expert review of precision medicine and drug development

相似文献

同项目论文

Expert review of precision medicine and drug development

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

TRAIL pathway targeting therapeutics.

Expert review of precision medicine and drug development

相似文献

同项目论文

Expert review of precision medicine and drug development

相关期刊

检索历史清除